Vext Science Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $16.50 million
- Book Value:
- Revenue TTM:
- $34.15 million
- Operating Margin TTM:
- Gross Profit TTM:
- $18.42 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Vext Science Inc had its IPO on under the ticker symbol VEXTF.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Vext Science Inc has a staff strength of 0 employees.
Shares of Vext Science Inc opened at $0.19 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.18 - $0.2, and closed at $0.2.
This is a +11.73% increase from the previous day's closing price.
A total volume of 52,776 shares were traded at the close of the day’s session.
In the last one week, shares of Vext Science Inc have increased by +9.11%.
Vext Science Inc's Key Ratios
Vext Science Inc has a market cap of $16.50 million, indicating a price to book ratio of 0.176 and a price to sales ratio of 0.3138.
In the last 12-months Vext Science Inc’s revenue was $34.15 million with a gross profit of $18.42 million and an EBITDA of $10.56 million. The EBITDA ratio measures Vext Science Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vext Science Inc’s operating margin was 11.06% while its return on assets stood at 2.18% with a return of equity of 10.72%.
In Q2, Vext Science Inc’s quarterly earnings growth was a negative -64.3% while revenue growth was a positive 4.8%.
Vext Science Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.06 per share while it has a forward price to earnings multiple of 5.2247 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vext Science Inc’s profitability.
Vext Science Inc stock is trading at a EV to sales ratio of 0.7781 and a EV to EBITDA ratio of 1.7493. Its price to sales ratio in the trailing 12-months stood at 0.3138.
Vext Science Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $121.37 million
- Total Liabilities
- $10.45 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Vext Science Inc ended 2023 with $121.37 million in total assets and $0 in total liabilities. Its intangible assets were valued at $121.37 million while shareholder equity stood at $72.73 million.
Vext Science Inc ended 2023 with $0 in deferred long-term liabilities, $10.45 million in other current liabilities, in common stock, $33.93 million in retained earnings and $2.07 million in goodwill. Its cash balance stood at $4.28 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $33.23 million.
Vext Science Inc’s total current assets stands at $38.57 million while long-term investments were $1.74 million and short-term investments were $0. Its net receivables were $3.63 million compared to accounts payable of $1.70 million and inventory worth $13.62 million.
In 2023, Vext Science Inc's operating cash flow was $0 while its capital expenditure stood at $359040.
Comparatively, Vext Science Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Vext Science Inc stock is currently trading at $0.2 per share. It touched a 52-week high of $0.2676 and a 52-week low of $0.2676. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.19 and 200-day moving average was $0.19 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 1890.6% of the company’s stock are held by insiders while 863.7% are held by institutions.
Frequently Asked Questions About Vext Science Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. It is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, and Herbal Wellness brands. In addition, it provides management, advisory, cultivation, and dispensary services to entities in the cannabis field through joint operations agreements. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.